Prevention

Scientists in China have successfully inserted a tuberculosis-resistance gene into the bovine genome, without any off-target genetic effects.

Addison Biological Laboratory, Inc. announces the approval of the world's first commercial Moraxella bovoculi vaccine for the prevention of pinkeye in cattle. This USDA conditionally licensed product is the first

Delayed viral vaccination, along with use of an immunostimulant, could help reduce BRD morbidity and mortality in high-risk calves.

Pivotal efficacy studies conducted for FDA approval showed a 28 percent reduction in clinical mastitis.

Simply vaccinating calves is not enough to ensure immunization.

This week, AgriLabs, the largest U.S. animal health marketing and distribution business, announced that it has entered into the vaccine manufacturing business with a new USDA-licensed facility in Lincoln, Nebraska.

Protection against BVD remains critical especially among pregnant cattle.

How genomic information on BRD susceptibility can translate into industry outcomes.